How much funding has Century Therapeutics raised?

Century Therapeutics has raised $605.0M in total funding, most recently a Corporate Round.

Who are Century Therapeutics's investors?

Century Therapeutics's investors include Leaps by Bayer, TCGX, Bain Capital Life Sciences, Casdin Capital, RA Capital Management, Jerel Davis.

When was Century Therapeutics founded?

Century Therapeutics was founded in 2018.

Where is Century Therapeutics headquartered?

Century Therapeutics is headquartered in Philadelphia, Pennsylvania, United States.

What industry is Century Therapeutics in?

Century Therapeutics operates in Biotech, Healthcare.

How many employees does Century Therapeutics have?

Century Therapeutics has 51-200 employees.

Century Therapeutics

IPO

Engineering an Evolution in Cell Therapy

Public · Philadelphia, United States · Founded 2018 · $605.0M raised

Biotech

Healthcare

Headquarters: Philadelphia, Pennsylvania
Employees: 51–200
Founded: 2018
Business Model: B2B
Website: centurytx.com

Total Funding: $605.0M
Last Round: $135.0M Corporate RoundJan 2026
Rounds: 4
Type: Public

About

Century Therapeutics is an innovative biotechnology company building an allogeneic iPSC-derived cell therapy platform for autoimmune diseases and cancer. The company integrates gene editing, protein engineering, and advanced manufacturing to develop off-the-shelf NK and T cell therapies. Century is led by industry veterans with decades of R&D and commercialization experience in cell therapy.

Summary

Century Therapeutics is a Biotech company based in Philadelphia, United States, founded in 2018. It has raised $605.0M in total across 4 rounds, most recently a $135.0M Corporate Round round in Jan 2026. Investors include Leaps by Bayer, TCGX and Bain Capital Life Sciences.